First, when we analysed OLFM2 and OLFM4 relative mRNA expressions between NL and NAFLD in hepatic and jejunal samples, respectively, we only reported significant differences between groups in the case of OLFM2 (p = 0.005). The gene discussed is OLFM2; the disease is metabolic dysfunction-associated steatotic liver disease.